ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study

Overview of attention for article published in Medical Devices : Evidence and Research, November 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 27 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 79 followers.

ExtaviJect® 30G device for subcutaneous self-injection of INF beta-1b for #MultipleSclerosis: a prospective study http://t.co/7XtFN9XHAi

Reply Repost Favourite

ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospec... http://t.co/4L8YY37SzB

Reply Repost Favourite